| Literature DB >> 22984354 |
Amélie Yavchitz1, Isabelle Boutron, Aida Bafeta, Ibrahim Marroun, Pierre Charles, Jean Mantz, Philippe Ravaud.
Abstract
BACKGROUND: Previous studies indicate that in published reports, trial results can be distorted by the use of "spin" (specific reporting strategies, intentional or unintentional, emphasizing the beneficial effect of the experimental treatment). We aimed to (1) evaluate the presence of "spin" in press releases and associated media coverage; and (2) evaluate whether findings of randomized controlled trials (RCTs) based on press releases and media coverage are misinterpreted. METHODS ANDEntities:
Mesh:
Year: 2012 PMID: 22984354 PMCID: PMC3439420 DOI: 10.1371/journal.pmed.1001308
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Figure 1Flow diagram of the selected press releases and related articles.
General characteristics of articles.
| Characteristics | Subcharacteristics |
|
| Type of journal, | General medical journal | 32 (46) |
| Specialized medical journal | 38 (54) | |
| Funding source, | Profit or both profit and nonprofit | 33 (47) |
| None or nonprofit | 33 (47) | |
| Not reported | 4 (6) | |
| Sample size median; [IQR]; (min–max) | 112; [54–435]; (16–94,370) | |
| Experimental treatment, | Drug | 36 (51) |
| Surgery/procedure | 9 (13) | |
| Device | 5 (7) | |
| Therapeutic strategy | 7 (10) | |
| Participative intervention | 12 (17) | |
| Other | 1 (1) | |
| Comparator, | Placebo | 29 (41) |
| Active treatment | 32(46) | |
| Other | 9 (13) | |
| Primary outcomes clearly identified, | 61(87) | |
| Type of primary outcomes, | Efficacy | 61 (87) |
| Safety | 1 (1) | |
| Both | 4 (6) | |
| Unclear | 4 (6) | |
| Primary outcomes reported adequately, | 56 (80) | |
|
| All statistically significant | 34 (49) |
| All statistically nonsignificant | 24 (34) | |
| Some statistically significant/some not | 11 (16) | |
| Unclear | 1 (1) | |
| At least one “spin” | 28 (40) | |
| Type of “spin” | No acknowledgment of nonstatistically significant primary outcome | 14 (20) |
| Claiming equivalence when results failed to demonstrate a statistically significant difference | 5 (7) | |
| Focus on positive secondary outcome | 3 (4) | |
| Focus on inappropriate subgroup | 4 (6) | |
| Focus on within-group (or over-all within) comparison | 6 (9) | |
| Nonstatistically significant outcome reported as if they were significant | 3 (4) | |
| Ignored data of safety | 1 (1) | |
| Inadequate claim of safety | 4 (6) | |
| Inappropriate extrapolation | 6 (9) | |
| Other | 5 (7) |
Adequately, with effect size and precision or treatment effect in each arm with precision.
Numbers do not add up as the types of “spin” were not mutually exclusive.
General characteristics of press releases.
| Characteristics | Subcharacteristics |
|
| Origin, | Press officer | 40 (57) |
| Industry or institution | 30 (43) | |
| Easy access to full article, (i.e., direct link or the full reference) | 36 (51) | |
| Funding reported, | 25 (36) | |
| Design reported, | 70 (100) | |
| Sample size reported, | 65 (93) | |
| Length of follow-up reported, | 46 (66) | |
| Primary outcomes reported, | In words only | 29 (41) |
| Per arms | 30 (43) | |
| With effect size | 17 (24) | |
| Safety reported, | Mentioned | 24 (34) |
| Quantified | 14 (20) | |
| Limits reported, | 10 (14) | |
| Interview included, | Authors only | 40 (57) |
| Experts or editorialists only | 6 (9) | |
| Both | 12 (17) | |
| Article quotation reported, | 22 (31) | |
| At least one type of “spin” | 33 (47) | |
| Type of “spin” | No acknowledgment of nonstatistically significant primary outcome | 13 (19) |
| Claiming equivalence when results failed to demonstrate a statistically significant difference | 7 (10) | |
| Focus on positive secondary outcome | 5 (7) | |
| Focus on inappropriate subgroup | 4 (5) | |
| Focus on within-group (or over-all within) comparison | 11 (16) | |
| Nonstatistically significant outcome reported as if they were significant | 5 (7) | |
| Ignored data of safety | 3 (4) | |
| Inadequate claim of safety | 5 (7) | |
| Inappropriate extrapolation | 6 (9) | |
| Other “spin” | 2 (3) |
Numbers do not add up as the types of “spin” were not mutually exclusive.
Bivariate analysis of factors associated with and “spin” in the press releases.
| Characteristics | Subcharacteristics | “Spin” in Press Release |
|
| Journal | General | 11/32 (34) | 0.05 |
| Specialized | 22/38 (58) | — | |
| Funding source | Profit | 15/33 (45) | 0.8 |
| Nonprofit or not reported | 18/37 (49) | — | |
| Sample size | <112 | 22/35 (63) | 0.008 |
| ≥112 | 11/35 (31) | — | |
| Experimental treatment | Drug | 17/36 (47) | 1.0 |
| Other | 16/34 (47) | — | |
|
| All nonstatistically significant | 11/24 (46) | 0.9 |
| Other | 22/46 (48) | — | |
| Authors of press release | Press officer | 19/40 (48) | 0.9 |
| Other | 14/30 (47) | — | |
| “Spin” in abstract conclusion | Yes | 26/28 (93) | <0.001 |
| No | 7/42 (17) | — |
Bivariate analysis of factors associated with an overestimation of the benefit of the experimental treatment from the press releases as compared with the interpretation from articles.
| Characteristics | Subcharacteristics | Overestimation of the Benefit of the Experimental Treatment n/Total |
|
| Journal | General | 2/32 (6) | <0.001 |
| Specialized | 17/38 (45) | ||
| Funding source | Profit | 7/33 (21) | 0.3 |
| Nonprofit or not reported | 12/37 (32) | ||
| Sample size |
| 16/35 (46) | <0.001 |
|
| 3/35 (9) | ||
| Experimental treatment | Drug | 11/36 (31) | 0.5 |
| Other | 8/34 (24) | ||
|
| All nonstatistically significant | 10/24 (42) | 0.05 |
| Other | 9/46 (20) | ||
| Authors of press release | Press officer | 10/40 (25) | 0.6 |
| Other | 9/30 (30) | ||
| “Spin” in press releases | Yes | 16/33 (48) | <0.001 |
| No | 3/37 (8) |
Figure 2“Spin” in abstract conclusions, press releases, and news items.
Figure 3Examples of “spin” in abstracts, in press releases, and in related news items.